Verrica Pharmaceuticals Inc. (VRCA) by event type

VRCA moves most on analyst downgrades — a median of -1.16% at 30 minutes across 15 measured events. Each row is measured over the last three years and read against the price at its own news timestamp. Back to the VRCA overview →

By event type

How VRCA reacts across 2 measured event types.

EventEventsMedian 30-min% positiveMedian to close
Analyst downgrades
2,443 of 2,603
15-1.16%40%-7.56%
Rating reiterations
3,462 of 3,522
33-1.06%30%-3.18%

Last 3 years, pulled 2026-09-21. Reaction = percent move vs. the price at the news timestamp. Counts and medians only. The rank under each event type orders every name measured for it by median 30-min reaction, most positive first — so a low rank on a downgrade means this name falls harder than most, not that it moves less. Names with an identical median share a rank; a name the cross-section does not carry shows no rank rather than a guessed one. 4 further classes were observed with fewer than 10 measured events and are not published.

That’s how VRCA usually reacts — get an email when it moves on news →
Keep exploring

Every name measured for these event types: Analyst downgrades → · Rating reiterations → · VRCA overview →

Other Healthcare names, measured the same way

TickerEventsMedian 30-min% positive
Achieve Life Sciences, Inc. - Common Shares (ACHV)269-0.54%42%
CorMedix Inc. (CRMD)269-0.42%39%
CONMED Corporation (CNMD)268-0.11%47%
Codexis, Inc. (CDXS)2670.00%51%

Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not.